Increased Medial Degradation With Pseudo-Aneurysm Formation in Apolipoprotein E–Knockout Mice Deficient in Tissue Inhibitor of Metalloproteinases-1
- 21 January 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (2) , 333-338
- https://doi.org/10.1161/01.cir.0000044915.37074.5c
Abstract
Background— The tissue inhibitor of metalloproteinases-1 (TIMP-1) is expressed in atherosclerotic lesions, where it may play a critical role in regulating the activity of matrix metalloproteinases (MMPs). Several MMPs are overexpressed in the atherosclerotic plaque, and they are believed to contribute to the expansion and rupture of the lesion. Methods and Results— The Timp-1–knockout mouse model (Timp-1−/−) was crossed into the apolipoprotein E–knockout (apoE0) background. A study population of male apoE0 mice, half of them deficient in TIMP-1, was fed an atherogenic diet. After 10 weeks of the diet, the mean lesion sizes of the two groups of animals were not significantly different, and the average content of fibrillar collagen and macrophages in the lesions was similar. There was no sign of plaque hemorrhage, even after 22 weeks of high-fat diet, indicating that deficiency in TIMP-1 does not predispose to luminal rupture. However the atherosclerotic lesions of the Timp-1−/0 mice developed more aortic medial ruptures, in which all elastic lamellae of the media were degraded and infiltrated with macrophages, forming pseudo-microaneurysms. After 10 weeks of high-fat diet, the Timp-1−/0/apoE0 mice averaged 1.9±1.2 medial ruptures in the proximal aorta, compared with 0.5±0.7 for the apoE0 controls (PConclusions— These data strongly suggest that TIMP-1 plays a key role in preventing medial degradation associated with atherosclerosis through its ability to inhibit the MMPs that are involved in the disruption of the media.Keywords
This publication has 24 references indexed in Scilit:
- ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosisJournal of Clinical Investigation, 2001
- Proteinases in cardiovascular aneurysms and rupture: targets for therapy?Journal of Clinical Investigation, 2000
- Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient miceJournal of Clinical Investigation, 2000
- Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms.Journal of Clinical Investigation, 1998
- Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells.Journal of Clinical Investigation, 1998
- Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formationNature Genetics, 1997
- Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages.Journal of Clinical Investigation, 1995
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein EScience, 1992
- Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cellsPublished by Elsevier ,1992